Loading...

ASRT ASSERTIO HOLDINGS INC Company Mergers 8-K Filing

SSRT

SRT

ASSERTIO HOLDINGS INC

(ASRT)

2025 8-K

CEO Resignation

Leadership Change

CEO Departure & Appointment

Supply Agreement Update

Financial Statements

Financial Results

Stock Delisting Risk

Management Changes

Management Changes

Earnings Reports

Annual Meeting Approval

Appointment of CEO

Financial Results Announcement

Departure of Directors

Compliance Regained

Amendment - Transcript of E...

Financial Results and Board...

Resignation of Director

Departure of CEO and Appoin...

Appointment of Sravan Emany...

Financial Results and Execu...

Completion of Acquisition

Earnings Reports

Bylaws Amendment

Annual Meeting of Stockholders

Earnings Reports

Merger Agreement with Spect...

Merger Agreement

Regulation FD Disclosure

Earnings Reports

Exchange Agreement

Financial Results Announcement

External Links:

On October 7, 2025, Assertio Holdings, Inc. reported an amendment to a supply agreement for ROLVEDON drug substance, resulting in a mid-single digit percentage price reduction until October 2025, with provisions for future price changes.

AI Assistant

ASSERTIO HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.